CaviTAU®
Our products

CaviTAU®
Our products

Fields of application & application examples

Revolutionary ultrasound diagnostics in dentistry

Alveolar Transmission Ultrasound or Trans Alveolar Ultrasound Diagnostics, which is being implemented in CaviTAU®, is an imaging procedure in dentistry. This ultrasound diagnostic is necessary for the early detection and treatment of jawbone with low bone density, such as in areas of ischemic osteonecrosis.

In terms of the legally prescribed duty of care, CaviTAU® can be used as a non-invasive and cost-effective adjuvant for medical indication in the event of the following procedures:

Suspicion of jawbone necrosis with chronic facial pain

Suspicion of jawbone necrosis with immunological and tumour diseases

To protect the resilient bone during implantations to ensure the success of dental implants.

Application examples:

CaviTAU® detects so-called “bone marrow defects” in the jawbone as RANTES/CCL5 sources in the context of focal areas of inflammation.
By developing CaviTAU®, we are thus able to detect pre-inflammatory and pre-cancerous niches suffering from “silent inflammation” in the jawbone

CaviTAU® reveals reduced mineral density and focal areas of inflammation around implants.
By developing CaviTAU®, we are thus able to detect unexplained local, systemic complaints in implant wearers

CaviTAU® reveals reduced mineral density and focal areas of inflammation around teeth that have undergone root canal treatment.
By developing CaviTAU®, we are thus able to detect unexplained local, systemic complaints in patients who have undergone root canal treatment

CaviTAU® displays perfectly healed, stress-free jawbones for easy implant insertion.
By developing CaviTAU®, we are able to achieve higher rates of success for implants without “inexplicable” implant losses

CaviTAU® can also play an important role in the context of clinical research into factors that contribute to different forms of systemic diseases.

Why is it so difficult to diagnose fatty-degenerative osteolysis / osteonecrosis in the jawbone (FDOJ)?

The problem: On X-ray images, the bone dissolution of FDOJ areas cannot be determined with certainty. Suspected sites in the jaw can be confirmed or excluded with CaviTAU®. From the sum total of anamnesis, X-ray image OPG, X-ray image CBCT, lymphatic-palpatory findings and the CaviTAU® bone density measurement, you can finally get an idea of whether surgical intervention on the jaw is necessary.

  • [Al-Nawas B et al, Dental Implantation: Ulrasound Transmission Velocity to Evaluate Critical Bone Quality – An Animal Model. Ultraschall in Me/European Journal of Ultrasound 2008; 29:302-307.]
  • [Lechner, J. Validation of dental X-ray by cytokine RANTES – comparison of X-ray findings with cytokine overexpression in jawbone. Clinical, Cosmetic and Investigational Dentistry 2014:6 71–79]

Determine jawbone density with CaviTAU® ultrasound.

Locate potential cavities in the jawbone using trans-alveolar ultrasonography (Through Transmission Alveolar Ultrasonography, TAU).

CaviTAU®-Gel-Pads

Unique, patented gel pads

In-house developed gel pads were designed for successful use. These unique gel pads are used to maintain proper contact both enorally on the jawbone and extraorally on the outer cheek area. The size and properties of the enoral and extraoral pads differ and can each be ordered in 3 different pack sizes.

Determine jawbone density with CaviTAU® ultrasound.

Locate potential cavities in the jawbone using trans-alveolar ultrasonography (Through Transmission Alveolar Ultrasonography, TAU).
About CaviTAU®

CaviTAU®-Gel-Pads

Unique, patented gel pads

In-house developed gel pads were designed for successful use. These unique gel pads are used to maintain proper contact both enorally on the jawbone and extraorally on the outer cheek area. The size and properties of the enoral and extraoral pads differ and can each be ordered in 3 different pack sizes.

CaviTAU® THE ADVANTAGES IN YOUR HAND!
Menu